Renalytix PLC
LSE:RENX
Renalytix PLC
LSE:RENX
Price:
2.9
GBX
-7.94%
Market Cap:
£12.7m
Relative Value
The Relative Value of one
RENX
stock under the Base Case scenario is
0.63
GBX.
Compared to the current market price of 2.9 GBX,
Renalytix PLC
is
Overvalued by 78%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RENX
Relative Value
Base Case
0.63
GBX
Overvaluation 78%
Multiples Across Competitors
RENX Competitors Multiples
Renalytix PLC Competitors
Renalytix PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Renalytix PLC
LSE:RENX
|
12.7m GBP | 5.7 | -0.8 | -1.5 | -1.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | 21.9 | 43.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
30.5B USD | 9.5 | 33.5 | 24.3 | 25.2 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.3B AUD | 53.7 | 56.9 | 70.4 | 70.4 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.3 | 22.8 | 11.2 | 13.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
43.7B SEK | 18.7 | 81.4 | -112.2 | -112.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.7B USD | 4.2 | 41.1 | 14.8 | 22.8 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 7.1 | 19 | 15.2 | 16 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
20.4B CNY | 9.4 | -66.2 | -131 | -131 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | 267.9 | 4 290.1 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
228.5B INR | 7.5 | 34.4 | 22.7 | 25.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
